FindTrial
Sign In

Research on ILD-LC Risk Assessment Model Integrating Radiomics and Clinical Data

Research on ILD-LC Risk Assessment Model Integrating Radiomics and Clinical Data

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115055
Enrollment
Unknown
Registered
2025-12-22
Start date
2025-12-26
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial lung disease combined with lung cancer

Interventions

Interstitial group:None
Interstitial lung cancer group:None

Sponsors

Huzhou Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.The cases of ILD or ILD combined with LC that have been diagnosed in the center hospital of Huzhou City in the past 10 years; 2.Our hospital has chest CT data.

Exclusion criteria

Exclusion criteria: 1.Minor patients; 2.pregnant woman; 3.Medications or treatments for LC-induced ILD;

Design outcomes

Primary

MeasureTime frame
Risk factors for lung cancer;—

Countries

China

Contacts

Public ContactXuefei Shi

Huzhou Center Hospital

shixuefei1223@aliyun.com+86 572 281 7185

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026